Company
United StatesLee Duncan Cranmer, MD PhD, Seattle, WA – FDA Inspections
Inspection records and compliance data for Lee Duncan Cranmer, MD PhD in Seattle, Washington. 2 FDA inspections on record, 1 Form 483, last inspected September 06, 2024.
Company Profile
This profile covers Lee Duncan Cranmer, MD PhD based in Seattle, Washington, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected January 6, 2012. Last inspected September 6, 2024.
Most cited issue areas
- FD-1572, protocol compliance1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 6, 2024 | VAI | Human Drugs · Bioresearch Monitoring: Human Drugs | 1248875 |
| January 6, 2012 | NAI | Human Drugs · Bioresearch Monitoring | 765224 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Lee Duncan Cranmer, MD PhD
FEI Number
3009200773
Address
825 Eastlake Ave E, Seattle, Washington 98109, United States
Country
United States
ID: 21b3d8a0-bac3-4673-882f-cb974d25cf2f